More on NRXBF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.34 |
|
|||
| Open | $0.34 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.30 | ||||
| Day Low | $0.30 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1,600 | ||||
- Form D NurExone Biologic Inc.
- NurExone closes private placement raising C$627,795
- NurExone Announces Closing of Non-Brokered Private Placement
- NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update
- NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
- Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production
- NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
- NurExone to Participate in Water Tower Research Insights Conference on April 14, 2026
- Form D NurExone Biologic Inc.
- NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
Entities mentioned with NRXBF
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Show More...
